Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eisai
Eisai
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Seeking Alpha
Mon, 05/16/16 - 09:32 pm
Arena Pharmaceuticals
obesity
Orexigen
Belviq
Eisai
Vivus
Novo Nordisk
Qsymia
Victoza
Eisai slashes Belviq sales force as Arena marketing deal goes sour
Fierce Pharma Marketing
Thu, 03/24/16 - 04:40 pm
Eisai
layoffs
drug reps
Belviq
Arena Pharmaceuticals
Arena: Belviq Sales Still Slow - Will Eisai Stick Around?
Seeking Alpha
Mon, 03/21/16 - 09:01 am
Arena Pharmaceuticals
Belviq
Eisai
obesity
Eisai Says That the Recently Enacted IRTNMTA Should Result in a Longer PTE for FYCOMPA Patent
FDA Law Blog
Tue, 02/9/16 - 09:16 am
Eisai
IRTNMTA
FDA
Fycompa
Bristol-Myers, Pfizer and Eisai bet big biobucks on the Japanese market
Fierce Biotech
Mon, 02/1/16 - 11:20 pm
Japan
Bristol-Myers Squibb
Pfizer
Eisai
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Fierce Pharma
Wed, 01/20/16 - 08:40 am
Eisai
Lenvima
kidney cancer
FDA
priority review
Eisai and Arena Pharmaceuticals Announce FDA Acceptance of New Drug Application for Extended Release Formulation of Lorcaserin
Yahoo
Mon, 11/30/15 - 10:38 am
Eisai
Arena Pharmaceuticals
Belviq
FDA
Allergan counting on January formulary boost to jump-start Namzaric launch
Fierce Pharma Marketing
Wed, 11/11/15 - 09:54 am
Allergan
formulary
Namzaric
Alzheimer's disease
Aricept
Namenda
Eisai
Arena: Eisai Financials Offer Hints To Belviq Revenue In Q3
Seeking Alpha
Mon, 11/2/15 - 06:07 pm
Arena Pharmaceuticals
Eisai
Belviq
Advera Health Analytics: Novartis, Allergan Alzheimer's meds linked to abnormal behavior, blood pressure side effects
Fierce Pharma
Sun, 10/11/15 - 01:57 pm
Novartis
Allergan
Alzheimer's disease
Eisai
Exelon Patch
Namenda
Aricept
Drug maker loses lawsuit filed to regain ‘lost’ marketing time
Pharmalot
Mon, 10/5/15 - 05:59 pm
Eisai
Fycompa
Belviq
FDA
DEA
market exclusivity
No False Starts: FDA Prevails in Eisai Challenge Over NCE Exclusivity Start Dates for BELVIQ and FYCOMPA
FDA Law Blog
Thu, 10/1/15 - 09:13 am
FDA
Eisai
exclusivity
Belviq
Fycompa
Arena's Smoking Cessation Opportunity
Seeking Alpha
Thu, 08/13/15 - 09:50 am
Arena Pharmaceuticals
smoking cessation
Belviq
Eisai
Eisai and Halozyme Sign Collaboration Agreement to Investigate Halaven® (Eribulin) and PEGPH20 in Metastatic Breast Cancer
Yahoo
Sat, 08/1/15 - 10:04 am
Eisai
Halozyme
metastatic breast cancer
PEGPH20
Halaven
Eisai's launch for 'crown jewel' Lenvima tracking better than execs expected
Fierce Pharma Marketing
Tue, 07/28/15 - 12:00 pm
Eisai
Lenvima
thyroid cancer
Eisai Says New Cancer Drug Reaching Patients Faster Than Planned
Bloomberg
Fri, 07/24/15 - 08:28 am
Eisai
patients
Lenvima
thyroid cancer
Arena: Belviq Sales Slide Continues- Will Eisai Step Up To The Plate?
Seeking Alpha
Sat, 07/18/15 - 10:39 am
Arena Pharmaceuticals
Belviq
Eisai
Eisai sells RTP facility to Biogen; results in 35 layoffs
Bizjournals.com
Thu, 07/16/15 - 06:36 pm
Eisai
RTP
Biogen
layoffs
Eisai earns FDA nod for Fycompa
Pharma File
Mon, 06/22/15 - 11:05 am
Eisai
FDA
Fycoma
epilepsy
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »